Posts in tag

COPD


That’s despite being informed of the disease’s serious and potentially fatal complications Tuesday 16 May is Know Pneumonia Day, hosted by Lung Foundation Australia. Pneumonia is a potentially life-threatening lung infection …

More women are dying from COPD than breast and lung cancer combined, according to a new report The report, co-authored by Professor Christine Jenkins from The George Institute for Global …

NPS MedicineWise is launching a new educational program on chronic obstructive pulmonary disease for health professionals Recognising that COPD can be a complex and challenging condition for health professionals to …

Debbie Rigby rounds up the latest in research news Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist This paper proposes key steps for …

Debbie Rigby takes a look at the latest in research news Improving the Management of COPD in Women Chronic obstructive pulmonary disease (COPD) is a highly debilitating disease that represents …

Young smokers are being sought to take part in a product trial that may slow lung decline The GSK-funded trial, being run by The George Institute for Global Health, is …

Implementation of treatment plans for asthma is about to get easier for pharmacists, with the newly updated Australian Asthma Handbook clarifying facts on the latest medications on the market for …

Here are a few thoughts on optimising lung health, writes Ben Basger We know that cognitive and physical impairment (such as manual dexterity, visual issues and the inspiratory force able …

Debbie Rigby takes a look at the latest research relevant to community pharmacy Comparative efficacy of nonhormonal drugs on menopausal hot flashes Non-hormonal drugs are considered an option for treatment …

Australian research shows up to 90% of patients incorrectly use their inhalers for asthma or chronic obstructive pulmonary disease (COPD) The National Asthma Council Australia is urging pharmacists and other …

Novartis has welcomed the concurrent publication and presentation of findings from the FLAME study in the New England Journal of Medicine and at the 2016 American Thoracic Society International Conference …

Boehringer Ingelheim has announced the availability of the first tiotropium-based combination therapy on the PBS for the treatment of chronic obstructive pulmonary disease (COPD).